FindTrial
Sign In

5-year follow up of the MESIFOS cohort

5-year follow up of the MESIFOS cohort - MESIFOS 5-year follow up

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33061
Enrollment
131
Registered
2009-12-16
Start date
2009-08-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychotic disorders

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participation in the MESIFOS trial

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Course of the illness is the primary outcome measure. But "course" is a composite construct. Of the measures used in this study, the following are related to course and thus are primary: - The number of patients with one or more relapses since the end of the trial - Number of patients currently in remission (symptoms) - Number of patients currently recovered (symptoms and functioning) - Level of socaal functioning - Quality of Life - Within the group of successfully discontinued patients: how many are still discontinued without sustaining any relapse.—

Secondary

MeasureTime frame
Use of medication and its relationship with relapses. Quality of life—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)